rs28914833

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting

The NM_001045.6(SLC6A4):​c.1393T>C​(p.Phe465Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000225 in 1,613,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. F465F) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

SLC6A4
NM_001045.6 missense

Scores

3
3
12

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 5.35

Publications

23 publications found
Variant links:
Genes affected
SLC6A4 (HGNC:11050): (solute carrier family 6 member 4) This gene encodes an integral membrane protein that transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons. The encoded protein terminates the action of serotonin and recycles it in a sodium-dependent manner. This protein is a target of psychomotor stimulants, such as amphetamines and cocaine, and is a member of the sodium:neurotransmitter symporter family. A repeat length polymorphism in the promoter of this gene has been shown to affect the rate of serotonin uptake. There have been conflicting results in the literature about the possible effect, if any, that this polymorphism may play in behavior and depression. [provided by RefSeq, May 2019]
SLC6A4 Gene-Disease associations (from GenCC):
  • autism spectrum disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0123232305).
BP6
Variant 17-30210571-A-G is Benign according to our data. Variant chr17-30210571-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 891507.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 172 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A4NM_001045.6 linkc.1393T>C p.Phe465Leu missense_variant Exon 11 of 15 ENST00000650711.1 NP_001036.1 P31645-1B2R7Y7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A4ENST00000650711.1 linkc.1393T>C p.Phe465Leu missense_variant Exon 11 of 15 NM_001045.6 ENSP00000498537.1 P31645-1

Frequencies

GnomAD3 genomes
AF:
0.00113
AC:
172
AN:
152044
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00403
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000307
AC:
77
AN:
251136
AF XY:
0.000302
show subpopulations
Gnomad AFR exome
AF:
0.00437
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000131
AC:
191
AN:
1461732
Hom.:
0
Cov.:
31
AF XY:
0.000129
AC XY:
94
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.00448
AC:
150
AN:
33468
American (AMR)
AF:
0.0000671
AC:
3
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111938
Other (OTH)
AF:
0.000248
AC:
15
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00113
AC:
172
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.00125
AC XY:
93
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00402
AC:
167
AN:
41514
American (AMR)
AF:
0.000131
AC:
2
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68006
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000868
Hom.:
0
Bravo
AF:
0.00120
ESP6500AA
AF:
0.00431
AC:
19
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000379
AC:
46

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Behavior disorder Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

SLC6A4-related disorder Benign:1
Jul 27, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.53
D;D;T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.093
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.84
.;T;T
MetaRNN
Benign
0.012
T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
0.84
L;L;.
PhyloP100
5.3
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-5.0
D;D;D
REVEL
Benign
0.21
Sift
Benign
0.039
D;D;T
Sift4G
Benign
0.15
T;T;T
Polyphen
0.0090
B;B;.
Vest4
0.37
MutPred
0.27
Loss of methylation at K460 (P = 0.1137);Loss of methylation at K460 (P = 0.1137);Loss of methylation at K460 (P = 0.1137);
MVP
0.36
MPC
0.53
ClinPred
0.076
T
GERP RS
5.0
Varity_R
0.72
gMVP
0.61
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28914833; hg19: chr17-28537589; API